chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: M
Vaccine: FLU3
Symptoms: Anal fistula, CSF glucose, Depression, Dyskinesia, Dysstasia
Clinical narrative: Immediate numbness in both legs (especially feet), pelvic region and back pain after receiving a "flu shot". Increasing leg weakness resulting in hospital admission on 11/05. ICU and mechanical ventilation on 11/08. Plasmaphersis-11/22, IVIG-11/09, diagnose: probable Guillain- [[name]] Syndrome.  2/16/07 Received medical records from hospitalization from 11/5/06-1/12/07 which reveal patient experienced numbness of LEs from umbilicus down, low back pain & leg weakness & recurrent falls beginning almost immediately after receiving flu vax.  Seen in outlying ER & transferred to higher level care facility.  Exam revealed mild weakness of dorsiflexion bilaterally.  DTRs absent.  Diminished pinprick of LEs.  Sitnificant ataxia on finger to nose testing.  Difficulty sitting w/o support due to truncal ataxia.  Unable to stand due to severe ataxia. Declined on 3 days & required intubation.  Tx w/IVIG but continued to decline rapidly & developed flaccid quadriplegia, areflexia, bifacial weakness w/incomplete eye closure, dificulty w/[[name]] movement & tongue control.  Plasma exchange done but continued to deteriorate.  Second course of plasma exchange done & patient did improve.  Transferred to rehab hospital. Follow up EMG in 12/06 revealed severe GBS w/axonal features.  No EMG reports included.  T/C to hospital to request same. FINAL DX: Guillain [[name]] Syndrome; HTN; hyponatremia; respiratory failure; s/p trach & PEG tube; exposure keratoconjunctivitia; depression; and porrible perianal fistula. 2/22/07 Received EMG/NCS reports of 11/8/06 which revealed results c/w gen peripheral neuropathy which was neither axonal nor demyelinating in nature; report of 12/13/06 revealed evidence of a severe generalized sensorimotor peripheral neuropathy w/ a component of axonal degeneration. Follow-up: At the time of discharge from the hospital (1/12/07) patient still demonstrated "flaccid quadriplegia and areflexia" requiring ventilation support, but did not show improved pupillary response, eye movements, and tongue / [[name]] movement.
Age: 66.0
Sex: M
Vaccine: FLU3
Symptoms: Eye disorder, Full blood count, Guillain-Barre syndrome, Hypoaesthesia, Hyponatraemia
Clinical narrative: Immediate numbness in both legs (especially feet), pelvic region and back pain after receiving a "flu shot". Increasing leg weakness resulting in hospital admission on 11/05. ICU and mechanical ventilation on 11/08. Plasmaphersis-11/22, IVIG-11/09, diagnose: probable Guillain- [[name]] Syndrome.  2/16/07 Received medical records from hospitalization from 11/5/06-1/12/07 which reveal patient experienced numbness of LEs from umbilicus down, low back pain & leg weakness & recurrent falls beginning almost immediately after receiving flu vax.  Seen in outlying ER & transferred to higher level care facility.  Exam revealed mild weakness of dorsiflexion bilaterally.  DTRs absent.  Diminished pinprick of LEs.  Sitnificant ataxia on finger to nose testing.  Difficulty sitting w/o support due to truncal ataxia.  Unable to stand due to severe ataxia. Declined on 3 days & required intubation.  Tx w/IVIG but continued to decline rapidly & developed flaccid quadriplegia, areflexia, bifacial weakness w/incomplete eye closure, dificulty w/[[name]] movement & tongue control.  Plasma exchange done but continued to deteriorate.  Second course of plasma exchange done & patient did improve.  Transferred to rehab hospital. Follow up EMG in 12/06 revealed severe GBS w/axonal features.  No EMG reports included.  T/C to hospital to request same. FINAL DX: Guillain [[name]] Syndrome; HTN; hyponatremia; respiratory failure; s/p trach & PEG tube; exposure keratoconjunctivitia; depression; and porrible perianal fistula. 2/22/07 Received EMG/NCS reports of 11/8/06 which revealed results c/w gen peripheral neuropathy which was neither axonal nor demyelinating in nature; report of 12/13/06 revealed evidence of a severe generalized sensorimotor peripheral neuropathy w/ a component of axonal degeneration. Follow-up: At the time of discharge from the hospital (1/12/07) patient still demonstrated "flaccid quadriplegia and areflexia" requiring ventilation support, but did not show improved pupillary response, eye movements, and tongue / [[name]] movement.
Age: 66.0
Sex: M
Vaccine: FLU3
Symptoms: Hypoxia, Keratitis, Muscular weakness, Neuropathy peripheral, Paresis
Clinical narrative: Immediate numbness in both legs (especially feet), pelvic region and back pain after receiving a "flu shot". Increasing leg weakness resulting in hospital admission on 11/05. ICU and mechanical ventilation on 11/08. Plasmaphersis-11/22, IVIG-11/09, diagnose: probable Guillain- [[name]] Syndrome.  2/16/07 Received medical records from hospitalization from 11/5/06-1/12/07 which reveal patient experienced numbness of LEs from umbilicus down, low back pain & leg weakness & recurrent falls beginning almost immediately after receiving flu vax.  Seen in outlying ER & transferred to higher level care facility.  Exam revealed mild weakness of dorsiflexion bilaterally.  DTRs absent.  Diminished pinprick of LEs.  Sitnificant ataxia on finger to nose testing.  Difficulty sitting w/o support due to truncal ataxia.  Unable to stand due to severe ataxia. Declined on 3 days & required intubation.  Tx w/IVIG but continued to decline rapidly & developed flaccid quadriplegia, areflexia, bifacial weakness w/incomplete eye closure, dificulty w/[[name]] movement & tongue control.  Plasma exchange done but continued to deteriorate.  Second course of plasma exchange done & patient did improve.  Transferred to rehab hospital. Follow up EMG in 12/06 revealed severe GBS w/axonal features.  No EMG reports included.  T/C to hospital to request same. FINAL DX: Guillain [[name]] Syndrome; HTN; hyponatremia; respiratory failure; s/p trach & PEG tube; exposure keratoconjunctivitia; depression; and porrible perianal fistula. 2/22/07 Received EMG/NCS reports of 11/8/06 which revealed results c/w gen peripheral neuropathy which was neither axonal nor demyelinating in nature; report of 12/13/06 revealed evidence of a severe generalized sensorimotor peripheral neuropathy w/ a component of axonal degeneration. Follow-up: At the time of discharge from the hospital (1/12/07) patient still demonstrated "flaccid quadriplegia and areflexia" requiring ventilation support, but did not show improved pupillary response, eye movements, and tongue / [[name]] movement.
Age: 66.0
Sex: M
Vaccine: FLU3
Symptoms: Protein total, Respiratory failure, Tongue disorder, Tracheostomy, White blood cell count
Clinical narrative: Immediate numbness in both legs (especially feet), pelvic region and back pain after receiving a "flu shot". Increasing leg weakness resulting in hospital admission on 11/05. ICU and mechanical ventilation on 11/08. Plasmaphersis-11/22, IVIG-11/09, diagnose: probable Guillain- [[name]] Syndrome.  2/16/07 Received medical records from hospitalization from 11/5/06-1/12/07 which reveal patient experienced numbness of LEs from umbilicus down, low back pain & leg weakness & recurrent falls beginning almost immediately after receiving flu vax.  Seen in outlying ER & transferred to higher level care facility.  Exam revealed mild weakness of dorsiflexion bilaterally.  DTRs absent.  Diminished pinprick of LEs.  Sitnificant ataxia on finger to nose testing.  Difficulty sitting w/o support due to truncal ataxia.  Unable to stand due to severe ataxia. Declined on 3 days & required intubation.  Tx w/IVIG but continued to decline rapidly & developed flaccid quadriplegia, areflexia, bifacial weakness w/incomplete eye closure, dificulty w/[[name]] movement & tongue control.  Plasma exchange done but continued to deteriorate.  Second course of plasma exchange done & patient did improve.  Transferred to rehab hospital. Follow up EMG in 12/06 revealed severe GBS w/axonal features.  No EMG reports included.  T/C to hospital to request same. FINAL DX: Guillain [[name]] Syndrome; HTN; hyponatremia; respiratory failure; s/p trach & PEG tube; exposure keratoconjunctivitia; depression; and porrible perianal fistula. 2/22/07 Received EMG/NCS reports of 11/8/06 which revealed results c/w gen peripheral neuropathy which was neither axonal nor demyelinating in nature; report of 12/13/06 revealed evidence of a severe generalized sensorimotor peripheral neuropathy w/ a component of axonal degeneration. Follow-up: At the time of discharge from the hospital (1/12/07) patient still demonstrated "flaccid quadriplegia and areflexia" requiring ventilation support, but did not show improved pupillary response, eye movements, and tongue / [[name]] movement.
Age: 68.0
Sex: M
Vaccine: PPV, TD
Symptoms: Cellulitis, Injection site reaction
Clinical narrative: Cellulitis at site entire upper 1/2 of upper arm. Event may be related to patients own aftercare. (OMIC).
Age: 1.01
Sex: F
Vaccine: MMRV, PNC
Symptoms: Herpes zoster
Clinical narrative: Seen in office 12/13/06 diagnose: Shingles, mainly affected on right side sacrum, right thigh. Afebrile, no history of fever prior to breakout or any other signs/symptoms.
Sex: F
Vaccine: PPV
Symptoms: Asthma, Cough, Hypertension, Injection site erythema, Neck pain
Clinical narrative: Large area of redness to injection site. Tender to touch, cough, sore neck, pain in arm and right thigh.   PCP MR received revealing a 61 yr old in for check up.  Pneumovax given and 2 days later pt. c/o that she was having headaches, neck aches, non-productive cough and sinus drainage. Also c/o throbbing pain in the right arm where vax. was given, as well as numbness and pain in the right thigh, fever, chills, aches. Sent to ER by PCP for labs and IV antibiotics for r/o cellulitis/abcsess.   Hospital record received revealing a 3 day admission for reaction, status post pneumococcal vaccine. Cellulitis vs. allergic reaction.  PE revealed a 5 cm. area of well-circumscribed erythema c/w cellulitis. Tx'd with vancomycin IV and d/c'd home on doxycycline. Discharge Diagnosis: Cellulitis. F/U 2 1/2 weeks post vax: Small area (1.5cm) of induration remains, dramatically improved.
Sex: F
Vaccine: PPV
Symptoms: Pain, Tenderness, Upper respiratory tract infection, Urinary tract infection, White blood cell count
Clinical narrative: Large area of redness to injection site. Tender to touch, cough, sore neck, pain in arm and right thigh.   PCP MR received revealing a 61 yr old in for check up.  Pneumovax given and 2 days later pt. c/o that she was having headaches, neck aches, non-productive cough and sinus drainage. Also c/o throbbing pain in the right arm where vax. was given, as well as numbness and pain in the right thigh, fever, chills, aches. Sent to ER by PCP for labs and IV antibiotics for r/o cellulitis/abcsess.   Hospital record received revealing a 3 day admission for reaction, status post pneumococcal vaccine. Cellulitis vs. allergic reaction.  PE revealed a 5 cm. area of well-circumscribed erythema c/w cellulitis. Tx'd with vancomycin IV and d/c'd home on doxycycline. Discharge Diagnosis: Cellulitis. F/U 2 1/2 weeks post vax: Small area (1.5cm) of induration remains, dramatically improved.
Age: 86.0
Sex: F
Vaccine: FLU3
Symptoms: Dyspnoea, Sensory disturbance
Clinical narrative: Patient complain of "heaviness" in tongue about 20 minutes after injection and sensation of labored breathing. Patient maintained adequate saturation  (>98%) did have any objective finding consistent without anaphylatoid reaction. Patient given ice and Celestone and closely followed totally abated within 1 hour.
Age: 0.17
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Diarrhoea, Haematochezia, Laboratory test abnormal
Clinical narrative: Diarrhea started on 11/18/06-Blood and mucus in stools.
Age: 45.0
Sex: F
Vaccine: FLU3
Symptoms: Diarrhoea, Headache, Pain, Pyrexia
Clinical narrative: 4 days worse, 1st 2 days bodyaches, headache (base of skull) low grade fever 99.5 degrees- 100.5 F, loose stools 1-2 days, hyperactive bowel stones.
Age: 17.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site rash, Nausea
Clinical narrative: Noticed slight red rash around injection site 11/17/06 6:30 am complain slight nausea.
Age: 38.0
Sex: F
Vaccine: FLUN3, PPV
Symptoms: Body temperature decreased, Injection site erythema, Injection site swelling, Injection site warmth, Insomnia
Clinical narrative: On 12/1/06 patient had immunization Flumist, left arm had small amount of soreness at injection site on 12/1. 12/2 increase soreness with small red spots at injection site. 12/3 Difficulty sleeping  related to arm pain, increase redness, muscle aches, low-grade temperature. Later in night had vomiting, increase achiness, nausea, swelling et 2 x 2" redness at site. 12/4 increase soreness, increase redness (3 x 4"), increase swelling, warm, tender continues to feel achy. Vital signs on 12/04/06 100/76, 99.4 oral, Pulse=104. Patient given Tylenol #3 for pain and fever.
Age: 38.0
Sex: F
Vaccine: FLUN3, PPV
Symptoms: Myalgia, Pain, Vomiting
Clinical narrative: On 12/1/06 patient had immunization Flumist, left arm had small amount of soreness at injection site on 12/1. 12/2 increase soreness with small red spots at injection site. 12/3 Difficulty sleeping  related to arm pain, increase redness, muscle aches, low-grade temperature. Later in night had vomiting, increase achiness, nausea, swelling et 2 x 2" redness at site. 12/4 increase soreness, increase redness (3 x 4"), increase swelling, warm, tender continues to feel achy. Vital signs on 12/04/06 100/76, 99.4 oral, Pulse=104. Patient given Tylenol #3 for pain and fever.
Age: 81.0
Sex: M
Vaccine: FLUX
Symptoms: Herpes zoster, Infection
Clinical narrative: Developed shingles.
Age: 22.0
Sex: M
Vaccine: FLUN3
Symptoms: Dysphagia, Tongue disorder
Clinical narrative: As she left to go to her car noticed that her tongue felt odd and hurt to swallow so came back in to office, no SOB, no numbness, no tingling, no wheezing. Sensation mainly at base of tongue and in salivary glands, sublingual. Patient given Zyrtec 10 mg and observed, O2 saturation 100, Pulse 68 after domain. No signs/symptoms patient allowed to go home.
Age: 47.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injection site swelling, Myalgia, Rash
Clinical narrative: Heavy soreness to right arm-pain started Friday evening. Rectangle shaped rash around injection. Swelling of injection site. All started the evening of injection. Symptoms subsided today 12/11/06.
Age: 53.0
Sex: F
Vaccine: FLUX
Symptoms: Dyspnoea, Rash
Clinical narrative: Employee felt like she "needed more air, needed to open window in office" approx 30 minutes after receiving shots. Symptoms resolved within a few minutes after intervention and did not return. Developed fine light pink rash 11/2/06 on arms and legs. Rash resolved 11/9/06.
Age: 1.03
Sex: M
Vaccine: FLU3, HBHEPB, MMRV
Symptoms: Erythema, Injection site mass, Pyrexia
Clinical narrative: Lump on left thigh red (marble size) grade, high grade fever 2nd day post vaccine.
Age: 49.0
Sex: F
Vaccine: FLU3
Symptoms: Dizziness, Flushing, Labyrinthitis, Vertigo, Vomiting
Clinical narrative: 2 hours after shot felt flushed, dizzy. Vomited by 3.5 hours later. Had ENT, neuro evaluation. Diagnosed as labyrinthritis associated with vaccine. Still with dizziness 6 weeks later. Administered 10/17/06. Per report from doctor: Patient received flu vaccine on 10/27/06 and suffered a vertigo type reaction within a few hours after the vaccine was administered. Dr. discussed with patient. Patient states she has taken the flu vaccine for many years with difficulty. She received shot at about 8am and by 10am felt flushed and dizzy. This worsened and by 11:30 am she was vomiting. She has been evaluated by her internist as well as ENT and neurologist. They feel the reaction is probably associated with the vaccine and have diagnoses labyrinthitis. She is improving but still has some dizziness. She has been treated with antibiotics and steroids.
Age: 18.0
Sex: F
Vaccine: MNQ
Symptoms: Cellulitis, Injection site erythema, Injection site induration, Injection site warmth
Clinical narrative: Initial report received on 04/Aug/2006 from a healthcare professional. An 18-year-old female patient with no current illness had received a first intramuscular dose of Menactra, lot number U2117AA, in the left deltoid, on 01/Aug/2006. Twenty four hours post-immunization, the patient's left deltoid was red, warm, and indurated at the injection site that required medical evaluation. Per the reporter, there was a questionable diagnosis of cellulitis, but no cultures were performed. Treatment received was not reported. The reporter stated that a 27g 1/2 inch needle was used to administer the intramuscular injection. The recovery status of the patient was reported as not recovered. A corrective version was created for the sole purpose of amending the event of cellulitis to injection site cellulitis, and making the events of left deltoid red at the injection site, left deltoid warm at the injection site, and left deltoid indurated at the injection site as co-manifestations of the injection site cellulitis. No new medical information was received.
Age: 33.0
Sex: M
Vaccine: MNQ
Symptoms: Pain, Pyrexia
Clinical narrative: Initial report received on 29/Aug/2006 from a healthcare professional. A 33-year-old male patient, with no illness at the time of vaccination, had received an intramuscular, left deltoid injection of Menactra, lot number U2139AA, on 23/Aug/2006. The following day, the patient experienced "pain in his left arm, a swollen gland in the axillary area and fever for 24 hours of 101 degrees Fahrenheit". The event did not necessitate examination by a physician. At the time of this report, the event was resolving. Follow-up information received on 15/Sep/2006, Per the reporter, the patient did not have any illnesses, and was not taking any other medications at the time of the vaccination on 23/Aug/2006. The patient did not have any relevant diagnostic test/laboratory data performed for these adverse events. No further information is expected.
Age: 46.0
Sex: F
Vaccine: MNQ
Symptoms: Back pain, Body temperature decreased, Chills, Fatigue, Injection site pain
Clinical narrative: A 48-year-old female patient received an initial dose of Menactra, lot number U2154CA, administered in the left deltoid on 18/Sep/2006. The route of administration was not reported. Within eight hours, the patient developed a low grade fever of 99.2  degrees Fahrenheit, chills,  body aches and pain at the injection site. The patient also complained of fatigue. The following day, the patient developed increased fatigue and dark urine, which tested 3+ for blood. The patient also had left lower back pain, lower quadrant pain, a swollen lymph node in her right axilla which measured approximately 2 X 2 in size, and tenderness in both axillae. The patient self-medicated with Motrin. According to the reporter, a nurse practitioner will complete a urinalysis and will refer the patient to her primary care physician to rule out kidney stones. The patient's recovery status was not reported.
Age: 46.0
Sex: F
Vaccine: MNQ
Symptoms: Lymphadenopathy, Pain, Tenderness, Urine analysis abnormal
Clinical narrative: A 48-year-old female patient received an initial dose of Menactra, lot number U2154CA, administered in the left deltoid on 18/Sep/2006. The route of administration was not reported. Within eight hours, the patient developed a low grade fever of 99.2  degrees Fahrenheit, chills,  body aches and pain at the injection site. The patient also complained of fatigue. The following day, the patient developed increased fatigue and dark urine, which tested 3+ for blood. The patient also had left lower back pain, lower quadrant pain, a swollen lymph node in her right axilla which measured approximately 2 X 2 in size, and tenderness in both axillae. The patient self-medicated with Motrin. According to the reporter, a nurse practitioner will complete a urinalysis and will refer the patient to her primary care physician to rule out kidney stones. The patient's recovery status was not reported.
Age: 18.0
Sex: F
Vaccine: MNQ
Symptoms: Diarrhoea, Injection site erythema, Injection site warmth, Lactose intolerance, Nausea
Clinical narrative: Initial information received on 09/Oct/2006 from a consumer (the patient). An 18-year-old female patient received a dose of Menactra, lot number U1575AA, administered intra-muscularly in the left arm on 26/May/2006. On 27/May/2006, within 24 hours of vaccination, the patient developed a large red "bull's eye" area at the injection site. The patient was seen in an emergency room and treated with unspecified antibiotics and ice packs. The patient also reported that she was unable to eat dairy products and had diarrhea and nausea. The patient had no significant past medical history and no illnesses at the time of vaccination. She received the vaccine as a requirement for college. The injection site reaction resolved a month after onset. At the time of this report, the patient stated that she was still unable to eat diary products and the nausea and diarrhea continues. Follow-up information received from another company (reference number 1-81033439) on 13/Oct/2006. The information in this follow-up report was provided to the other company by the patient, and the case is not medically confirmed. The patient reported that two days post-immunization, on 28/May/2006 (previously reported as 27/May/2006), she developed a "bull's eye" circle at the injection site, which was also warm to touch. She went to the emergency room and was given antibiotics, but was not admitted. After this instance (exact date not reported), the patient "became lactose intolerant and cannot tolerate any diary products". No additional information was provided.
Age: 89.0
Sex: F
Vaccine: FLU3
Symptoms: Musculoskeletal stiffness, Myalgia
Clinical narrative: Soreness and stiffness at and around injection site lasting greater than 30 days. Has received anti inflammatory treatment.
Age: 0.38
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Lethargy, Rash macular
Clinical narrative: 15 minutes after vaccine were given, infant became lethargic and developed areas of blotchiness around head. BP 100/60, pulse 160. Pulse oximeter-95%. Lower extremities "blotchy". Benadryl 0.5ml. No respiratory difficulties. Observed for 1 hour blotchy areas subsided. Discharged to home mother given status post vaccine.
Age: 33.0
Sex: F
Vaccine: FLU3
Symptoms: Feeling hot, Injection site erythema, Pruritus
Clinical narrative: 3 days had the hot, pink, itching localized symptoms at site of injection. Fluzone administered on Dec 13 2006. Client waited till Dec 15 2006 to report condition.
Age: 1.03
Sex: F
Vaccine: FLU3, HEPA, MMRV
Symptoms: Muscular weakness, Staring, Vaccination complication
Clinical narrative: A day after receiving above vaccine on 11/14/06 mom states child was "weak" and "weird" with a "dazed"look to the eyed for about 2 days. On Monday child was acting different since she got the shots.
Age: 46.0
Sex: M
Vaccine: FLUN3
Symptoms: Headache
Clinical narrative: Patient received Flumist on 10/6/06. Approx 15-30 min after administration he began to experience a headache that progressively became worse by later that afternoon. Patient experienced headache for 1 1/2 weeks. Headache was described as dull but disturbing. Patient had to take extra strength Tylenol four times a day for 1 and 1/2 weeks to relieve pain.
Age: 39.0
Sex: F
Vaccine: TD
Symptoms: Injection site erythema, Pain
Clinical narrative: Minimal redness at injection site. Pain with movement of right arm/shoulder.
Age: 74.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Injection site nodule, Injection site reaction, Rash
Clinical narrative: The patient had local site reaction around the injection site-"bumps" red rash areas.
Age: 1.32
Sex: F
Vaccine: DTAP, IPV, VARCEL
Symptoms: Pyrexia
Clinical narrative: Patient received the 3 immunizations listed in box 13 on 11/27/06. Mom called reported patient developed tem 101-104 within 24hours. Treated with Tylenol with slight relief then treated with Motrin. Called Health center 12/1/06 to report above incident. Today temp 100 taking oral fluids with no problems. Mom will contact Pediatrician today.
Age: 2.0
Sex: M
Vaccine: DTAPH, HEPA, MMR, PNC
Symptoms: Convulsion, Diarrhoea, Otitis media
Clinical narrative: 2 days after immunizations had diarrhea all day. Next day fever. 4 days after immunizations had seizure. Taken to local hospital. Diagnosed with otitis media. Put on antibiotic. Details sketchy. Mom is Russian and doesn't speak English well. She was out of town when this occurred and relatives caring for child provided few details.
Age: 63.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Feeling hot, Pain, Swelling
Clinical narrative: Pain, swelling, redness, warmth. Started evening of injection. Used ice pack for treatment.
Age: 5.0
Sex: F
Vaccine: HEPA, VARCEL
Symptoms: Injection site swelling
Clinical narrative: Immunizations Hep A and Variavax given. Left arm swollen 6cm area at injection site.
Age: 1.25
Sex: M
Vaccine: DTAP, HIBV, MMR, VARCEL
Symptoms: Urticaria
Clinical narrative: Varicella vaccine breakthrough. Diagnosed in our office with Varicella on 12-8-06. Had 100 to 150 pox. No fever.
Age: 1.28
Sex: M
Vaccine: DTAP, VARCEL
Symptoms: Urticaria
Clinical narrative: Gave him Benadryl because he had welts on his back, belly, legs. No other symptoms though. (Could breathe fine and no fever).
Age: 0.04
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC
Symptoms: Wrong drug administered
Clinical narrative: Baby was administered vaccines as below. Baby was 2 weeks of age at administration. Baby's parent given information sheets for each of vaccines given. Prescription for infant Tylenol drops with instructions-if fever above 100.4 or pain give .4ml every 4-6 hours. Patient not evaluated by CPNP. After incident parent refused care at this facility didn't want child seen here.
Age: 55.0
Sex: M
Vaccine: FLU3
Symptoms: Urticaria
Clinical narrative: Patient developed diffuse urticarical rash on arms. Was given a start dose of flu vaccine prior to developing rash. Was given a prednisone taper to minimize rash.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Injection site inflammation, Tenderness
Clinical narrative: Patient received DTap #5, IPV #4, MMR #2 on 31 Mar 06. On 01 Apr 06 developed a inflammed area around injection site on Left thigh. Injection site erythema, 1-5 cm (dia) or mild tenderness within 24 hours.
Age: 46.0
Sex: F
Vaccine: HEPA
Symptoms: Pain
Clinical narrative: Severe pain in right arm.
Age: 30.0
Sex: F
Vaccine: TD
Symptoms: Influenza like illness, Myalgia, Pyrexia
Clinical narrative: Flu like symptoms, fever 101 for 24 hours. Arm sore. Took Tylenol.
Age: 1.55
Sex: F
Vaccine: DTAP
Symptoms: Decreased appetite, Erythema, Injection site induration, Oedema, Tenderness
Clinical narrative: 22 month old female received DTap vaccine on 12/12/2006. Mother noticed child developed a large erythematous and indurated area on the left thigh associated with slight reduction in appetite over the past 1-2 days. Symptom: Erythema start: 12/13/02006 Comment: Over the left lateral and anterior thigh. Symptom: Edema at injection site 30-50mm Start: 12/13/2006 Comment: Induration primarily at the left thigh laterally. Symptom: Tenderness Start: 12/13/2006 Comment: At the initial inoculation site to direct palpation.
Age: 1.38
Sex: F
Vaccine: DTAP, PNC
Symptoms: Erythema, Swelling
Clinical narrative: Swelling with erythema day after shot.
Age: 11.0
Sex: F
Vaccine: TDAP
Symptoms: Pyrexia
Clinical narrative: Approximately 2 hours after vaccination, child developed fever of 103.  Since immunization was given at school, child sent home and referred to private physician.
Age: 57.0
Sex: M
Vaccine: FLUX
Symptoms: Erythema, Feeling hot, Pain, Rash, Swelling
Clinical narrative: Pm of the day receiving the pneumonia vaccine. Left upper arm swollen, hard and very warm to touch. Had limited movement. This lasted into the next day. Today, 12/15/2006, have a red flat rash area on the muscle of the upper left arm. The pain is lessening, but remains tender.
Age: 11.0
Sex: M
Vaccine: FLU3
Symptoms: Dizziness, Hyperhidrosis, Syncope
Clinical narrative: Patient felt dizzy and blacked-out five minutes after receiving the influenza vaccine.  His mother was standing beside him and was able to catch him and prevent him from falling.  His extremities were diaphoretic. Blood pressures were 108/80 (left arm, seating) and 110/78 (left arm, supine).  Emergency service arrived but patient recovered and did not require hospitalization.  Patient was advised to take Benadryl 12.5mg every 4 to 6 hours if he developed a rash.
Age: 1.1
Sex: M
Vaccine: HIBV, MMR, PNC
Symptoms: Convulsion, Dehydration, Lethargy, Pyrexia, Rash
Clinical narrative: CHILD DEVELOPED FEVER OF 101 ON 12/07/2006. ON 12/08/2006 FEVER WAS UP TO 104 -105, PEAKING AT 105.3, ON THAT DAY HE ALSO DEVELOPED RASH AND MOTHER STATES HE SEEMS DEHYDRATED. WAS TAKEN TO MD WHERE HE SEIZURED SEVERAL TIMES. TAKEN TO EMERGENCY ROOM WHERE BLOOD TESTS WERE DONE TO RULE OUT BACTERIAL OR VIRAL INFECTIONS. TALKED TO MOTHER ON 12/11/2006 STILL FEBRILE (LOW GRADE) AND LETHARGIC. TALKED TO MOTHER AGAIN ON 12/15/2006, SHE STATES HE IS BACK TO NORMAL, NO FURTHER SEIZURE ACTIVITY.
Age: 0.2
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Rash, Urticaria
Clinical narrative: When this mother presented for the second set of shots on 12/05/2006 and advised the nurses in the clinic that after receiving the last set of immunizations on 10/31/2006 he developed "head to toe rash and raised whelts" about two hours after receiving the immunizations.  Both the ER physician and the family physician are not sure which immunization may have caused this reaction according to mother.  Child was given Benadryl and no further problems were encountered.  Since this child is not our health clinic patient (he only comes to the health department for shots) the nurses working the clinic on 12/05/2006 were not comfortable giving any immunizations without something in writing from the family physician.  Mother was advised that she needed to obtain something in writing regarding whether or not child should receive any further immunizations. Mother voiced understanding and will get information needed.
Age: 44.0
Sex: M
Vaccine: ANTH
Symptoms: Arthralgia, Bronchitis, Diarrhoea, Fatigue, Irritable bowel syndrome
Clinical narrative: Received first AVA vac 2/1991 with persistent lump x 2 months before resolution. 5/1991 experienced profound fatigue upon return home and considered gulf war syndrome as a dx. 1992 diarrhea 4-5/wk w/loose stool, self dx with IBS. 1993 & 2005 severe bronchitis. Has severe arthralgia right hip, elbow, and neck with 2006 dx to include gout, vascular necrosis hip, DDD/OA c-spine.
Age: 44.0
Sex: M
Vaccine: ANTH
Symptoms: Necrosis, Skin nodule
Clinical narrative: Received first AVA vac 2/1991 with persistent lump x 2 months before resolution. 5/1991 experienced profound fatigue upon return home and considered gulf war syndrome as a dx. 1992 diarrhea 4-5/wk w/loose stool, self dx with IBS. 1993 & 2005 severe bronchitis. Has severe arthralgia right hip, elbow, and neck with 2006 dx to include gout, vascular necrosis hip, DDD/OA c-spine.
Age: 52.0
Sex: F
Vaccine: FLUX, PPV
Symptoms: Diarrhoea, Pyrexia
Clinical narrative: High fever 130.2for 24 hours. Went down to 102. Third day very bad diarria.
Age: 0.7
Sex: M
Vaccine: DTAP, HIBV, MMR, VARCEL
Symptoms: Rash, Skin irritation, Swelling
Clinical narrative: SHOT SITE IRRITATED; SWELLING, RASH ON RIGHT THIGH
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Dyskinesia, Ear pain, Headache, Pyrexia, Tic
Clinical narrative: Child developed "tic" jerking of head on 11/13/06. Sometimes it was quite severe. Complained of earache on 11/10/06.  Had headache and fever on 12/06/06. Today, grandmother reports child has not had any jerking since 12/05/2006.   To see pediatric neurologist on 12/21/06.
Age: 14.0
Sex: F
Vaccine: HPV4
Symptoms: Rash erythematous
Clinical narrative: One week after injection, pt. has had a patchy, dry, erythemous rash 1 cm. in circumference show up intermittently on trunk and extremities.  Rash  remits and recurs.  No history of rash.
Age: 65.0
Sex: M
Vaccine: FLU3
Symptoms: Arthralgia
Clinical narrative: Aproximately 1 week after injection, patients states he developed severe joint pain in back hips feet elbows.  No fever.  Sought medical attention from primary doctor.
Age: 1.3
Sex: M
Vaccine: DTAP, HIBV, PNC
Symptoms: Erythema, Feeling hot, Pyrexia, Swelling
Clinical narrative: Child developed fever to 104 degrees with redness, swelling, warmth and tenderness of bilateral anterior thighs the morning after receiving his DTaP, Hib and Prevnar vaccines. He returned the following day for evaluation and was started on Keflex as well as continuing on Tylenol.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, VARCEL
Symptoms: Erythema, Feeling hot, Swelling
Clinical narrative: REDNESS, SWELLING, AND WARM TO THE TOUCH.
Sex: F
Vaccine: HPV4
Symptoms: Abdominal pain, Dizziness, Joint stiffness
Clinical narrative: Information has been received from a physician concerning a female (age not reported) with rheumatoid arthritis who on an unspecified date was vaccinated with HPV rL1 6 11 16 18 VLP vaccine (yeast). Subsequently, the patient developed dizziness, stiffness in joints and abdominal cramping. The patient sought unspecified medical attention. At the time of this report, the patient had recovered from the events (date unknown). Additional information has been requested.
Age: 5.0
Sex: F
Vaccine: FLUX, HEPA, TTOX, VARCEL
Symptoms: Rash, Urticaria
Clinical narrative: rash on face, hives all over body, was given 4 shots, 2 in each arm, unsure of which arm except tetnus
Age: 38.0
Sex: M
Vaccine: ANTH, ANTH
Symptoms: Arthralgia, Dizziness, Headache, Rash
Clinical narrative: Rash skin, red skin spot, hedache, joint pain, Headache, Dizziness.
Age: 38.0
Sex: M
Vaccine: ANTH, ANTH
Symptoms: Arthralgia, Dizziness, Erythema, Headache, Rash
Clinical narrative: Rash skin, red skin spot, hedache, joint pain, Headache, Dizziness.
Age: 8.0
Sex: M
Vaccine: FLUX, VARCEL
Symptoms: Fatigue, Pyrexia, Rash
Clinical narrative: Pox on leg and face, Fever (101 deg F), tired. Pox remained for 5 days. Treatment childrens Motrin.
Age: 58.0
Sex: F
Vaccine: FLU3
Symptoms: Blister, Pain, Rash pruritic
Clinical narrative: Patient developed painful, itchy rash with blisters.  Rash was in patches over most of her body. Rash developed approximately 24 hours after receiving flu vaccine.  She received the vaccine on 12/13/06.  She went to the doctor Saturday, 12/15 & was kept over night in the hospital.  She was much better Sunday morning, 12/16 & was discharged with prescription for Medrol Dosepak, Benadryl, & Vicodin.  Her husband says the doctor said reaction was probably from the flu shot. She said she had received flu shots in the past.  1/18/07 Received medical records from hospital which reveal patient admitted 12/16-12/17/06 following rapid progression of extensive rash 48-72 hours after flu fax.  Rash was exceedingly painful & pruitic. Also had fever, chills & malaise & night prior to admit had nausea & vomiting. Treated w/IV steroids & Benadryl.  Rash almost completely resolved within 24 hours.  D/C home on steroids, pain med & Benadryl.  Allergy referral was recommended. FINAL DX: Erythema multiforme, presumed secondary to flu vax; & asthma.
Age: 3.0
Sex: M
Vaccine: FLUX, HEPA
Symptoms: Discomfort, Pruritus, Pyrexia, Rash
Clinical narrative: fever on day two, and severe rashm with small bumps, it does not look like hives, because the bumps are very small, almost like hundreds of bug bites, severe itching, very uncomfortable, benadryl and over the counter hydrocordisone given per doc. suggestion, helped with itching, but sill has the rash.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Disorientation, Dizziness, Dyspnoea, Nausea, Syncope
Clinical narrative: Information has been received from a registered nurse concerning a 17 year old white female (121 pounds, 61.5 inches) who on 30 Oct 2006 was vaccinated with Gardisil (lot number 653978/0955F) intramuscularly. On 30 Oct 2006, after the injection , the patient left the examination room and arrived in the lobby (noted as less than 2 minutes) when the nurse was called to the lobby. The patient's mother stated the patient "passed out" for a few seconds. It was also noted that the patient was "faint" with a duration of less than 1 minute, had dizziness which lasted approximately 1.5 hours, had nausea for approximately 15 minutes, and her skin was clammy. The patients blood pressure and pulse were within normal limits. A cold wash cloth was applied to the patients neck. The patient was taken by wheelchair to the Emergency Department. The patient's mother reported that the Emergency Department visit was quick and the physician stated that the patient had a vasovagal response. On 31 Oct 2006, the patient was considered recovered from vasovagal response. Additional information is not available.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Syncope vasovagal
Clinical narrative: Information has been received from a registered nurse concerning a 17 year old white female (121 pounds, 61.5 inches) who on 30 Oct 2006 was vaccinated with Gardisil (lot number 653978/0955F) intramuscularly. On 30 Oct 2006, after the injection , the patient left the examination room and arrived in the lobby (noted as less than 2 minutes) when the nurse was called to the lobby. The patient's mother stated the patient "passed out" for a few seconds. It was also noted that the patient was "faint" with a duration of less than 1 minute, had dizziness which lasted approximately 1.5 hours, had nausea for approximately 15 minutes, and her skin was clammy. The patients blood pressure and pulse were within normal limits. A cold wash cloth was applied to the patients neck. The patient was taken by wheelchair to the Emergency Department. The patient's mother reported that the Emergency Department visit was quick and the physician stated that the patient had a vasovagal response. On 31 Oct 2006, the patient was considered recovered from vasovagal response. Additional information is not available.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Dizziness, Immediate post-injection reaction, Malaise, Presyncope, Syncope
Clinical narrative: Information has been received from a registered nurse concerning a 17 year old white female (121 pounds, 61.5 inches) who on 30 Oct 2006 was vaccinated with Gardisil (lot number 653978/0955F) intramuscularly. On 30 Oct 2006, after the injection , the patient left the examination room and arrived in the lobby (noted as less than 2 minutes) when the nurse was called to the lobby. The patient's mother stated the patient "passed out" for a few seconds. It was also noted that the patient was "faint" with a duration of less than 1 minute, had dizziness which lasted approximately 1.5 hours, had nausea for approximately 15 minutes, and her skin was clammy. The patients blood pressure and pulse were within normal limits. A cold wash cloth was applied to the patients neck. The patient was taken by wheelchair to the Emergency Department. The patient's mother reported that the Emergency Department visit was quick and the physician stated that the patient had a vasovagal response. On 31 Oct 2006, the patient was considered recovered from vasovagal response. Additional information is not available.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4, HPV4
Symptoms: Syncope
Clinical narrative: Information has been received from a registered nurse concerning a 17 year old white female (121 pounds, 61.5 inches) who on 30 Oct 2006 was vaccinated with Gardisil (lot number 653978/0955F) intramuscularly. On 30 Oct 2006, after the injection , the patient left the examination room and arrived in the lobby (noted as less than 2 minutes) when the nurse was called to the lobby. The patient's mother stated the patient "passed out" for a few seconds. It was also noted that the patient was "faint" with a duration of less than 1 minute, had dizziness which lasted approximately 1.5 hours, had nausea for approximately 15 minutes, and her skin was clammy. The patients blood pressure and pulse were within normal limits. A cold wash cloth was applied to the patients neck. The patient was taken by wheelchair to the Emergency Department. The patient's mother reported that the Emergency Department visit was quick and the physician stated that the patient had a vasovagal response. On 31 Oct 2006, the patient was considered recovered from vasovagal response. Additional information is not available.
Age: 0.17
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, RV5, RV5
Symptoms: Abdominal pain, Crying, Flatulence, Screaming
Clinical narrative: Information has been received from a physician concerning a 9-week-old male, with no medical history or allergies, who on 03-NOV-2006 was vaccinated PO with the first 2.0 mL dose of Rotateq (lot # 655175/0849F). There was no concomitant therapy. The physician reported that 05-NOV-2006 the patient experienced uncontrolled screaming for over an hour. He quieted down after another 30 minutes. On the morning of 06-NOV-2006 he was eating and fine. Later that afternoon he was screaming again. The patient was sent to the emergency room and had an ultrasound and an x-ray. He was later transported to another hospital to rule out intussusception. The patient was examined and sent home with no admission required. It was reported that the patient had recovered. No product quality complaint was involved. No other information was provided. Additional information was received from the reporting physician who confirmed, via telephone call, that intussusception was ruled-out and that no formal diagnosis was made. She indicated that an x-ray and abdominal ultrasound simply revealed air in the GI tract. The physician noted that the patient was fine. Additional information has been requested.
Age: 0.17
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC, RV5, RV5
Symptoms: Screaming
Clinical narrative: Information has been received from a physician concerning a 9-week-old male, with no medical history or allergies, who on 03-NOV-2006 was vaccinated PO with the first 2.0 mL dose of Rotateq (lot # 655175/0849F). There was no concomitant therapy. The physician reported that 05-NOV-2006 the patient experienced uncontrolled screaming for over an hour. He quieted down after another 30 minutes. On the morning of 06-NOV-2006 he was eating and fine. Later that afternoon he was screaming again. The patient was sent to the emergency room and had an ultrasound and an x-ray. He was later transported to another hospital to rule out intussusception. The patient was examined and sent home with no admission required. It was reported that the patient had recovered. No product quality complaint was involved. No other information was provided. Additional information was received from the reporting physician who confirmed, via telephone call, that intussusception was ruled-out and that no formal diagnosis was made. She indicated that an x-ray and abdominal ultrasound simply revealed air in the GI tract. The physician noted that the patient was fine. Additional information has been requested.
Age: 0.5
Sex: M
Vaccine: DTAP, HIBV, PNC, DTAP, HIBV, IPV, PNC
Symptoms: Bacterial infection, Brain oedema, Cerebrovascular accident, Convulsion, Cough
Clinical narrative: A six month old male patient, who had a concurrent diagnosis of mild upper respiratory infection with a cough fussiness, and who was afebrile, had received a third dose of ActHib, lot number UA850AA (lot number W1231-2), a second dose of IPOL, lot number W1156-2, a third dose of Tripedia, lot number U1006BA, and a dose of Prevnar, lot number 493378 on 08 December 2003 at 11:30 am. The patients two older siblings were diagnosed with influenza around the time of the visit, both having fever of 104.0 to 105.0 degrees F. The patient went home after the immunization, and slept for approximately four hours. the mother woke the patient at around 17:00 pm, five and a half hours post immunization, and the patient was febrile. His temperature was 103.0 degrees F, and the mother called the doctors office because she was concerned. The mother was told that the fever was probably from the vaccinations the patient had received earlier, and to give him some Tylenol. Approximately four and a half hours later, around 21:30pm, the patient's fever increased to 103.3 degrees F, and he was having inconsolable crying that lasted all night ling, and he had difficulty breathing (mother stated she heard noise when the child would breath). The mother stated that she used a nebulizer to try to reduce the patients breathing difficulty. The following morning, the mother took the patient to the physicians office for evaluation. The patient was still in respiratory distress with an oxygen saturation of 90%. The patient was taken to the emergency room, and on route to the hospital he went into respiratory failure and was intubated. The patient was diagnosed with influenza type A and croup. treatment received and diagnostic performed were not reported. The following day, the patient was extubated and appeared to be doing better. Two days later, the patient still had a fever and his symptoms worsened and his lungs collapsed with Pneumococcal meningitis. Strep pneumonia and septic shock. The patient also suffered strokes. Treatments received and diagnostic performed other than the spinal tap were not reported. The patient was discharged from the hospital on 14 January 2004, 36 days after admission. Per the mother, the patient is deaf and has cochlear implants as a result of the meningitis. Three areas of his brain are affected. The left body side is affected (the mother did not specify how it was affected). The patients left leg is shouter in length then the right, and he wears a brace. At the time of this report, the patient had not recovered.